The Secondary Hyperoxaluria Drug Market is witnessing an unprecedented surge in clinical interest and financial valuation. Unlike primary hyperoxaluria, which is a rare genetic defect, secondary hyperoxaluria is an acquired condition often resulting from underlying gastrointestinal disorders, such as Crohn’s disease or the aftermath of bariatric surgery, leading to excessive oxalate a... https://www.databridgemarketresearch.com/